InSilico Medicine Cayman TopCo

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by InSilico Medicine Cayman TopCo"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -34.55% vs 67.16% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1,959.00% vs 91.95% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "438.40",
          "val2": "669.80",
          "chgp": "-34.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-430.40",
          "val2": "-244.10",
          "chgp": "-76.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.60",
          "val2": "0.70",
          "chgp": "128.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-41.10",
          "val2": "-1.40",
          "chgp": "-2,835.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,746.70",
          "val2": "-133.40",
          "chgp": "-1,959.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,066.60%",
          "val2": "-434.90%",
          "chgp": "-63.17%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

438.40

669.80

-34.55%

Operating Profit (PBDIT) excl Other Income

-430.40

-244.10

-76.32%

Interest

1.60

0.70

128.57%

Exceptional Items

-41.10

-1.40

-2,835.71%

Consolidate Net Profit

-2,746.70

-133.40

-1,959.00%

Operating Profit Margin (Excl OI)

-1,066.60%

-434.90%

-63.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -34.55% vs 67.16% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -1,959.00% vs 91.95% in Dec 2024

All Annual Results